Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...